There wasn’t much to get excited about the last time Pfizer (NYSE: PFE) reported its quarterly results. While the big pharma company beat analysts’ consensus earnings estimate, it also posted a 2% year-over-year revenue decline.
Pfizer announces its third-quarter results before the market opens on Oct. 31. Will the company give investors a Halloween treat — or a disappointing trick? Here are three key things to watch that will make the difference.